Peachtree Investment Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,802
| Closed | -$572K | – | 120 |
|
|
2024
Q3 | $572K | Sell |
4,802
-5,377
| -53% | -$640K | 0.22% | 45 |
|
|
2024
Q2 | $1.45M | Buy |
10,179
+2,613
| +35% | +$373K | 0.57% | 24 |
|
|
2024
Q1 | $971K | Buy |
7,566
+5,352
| +242% | +$687K | 0.39% | 32 |
|
|
2023
Q4 | $229K | Sell |
2,214
-1,148
| -34% | -$119K | 0.09% | 81 |
|
|
2023
Q3 | $306K | Sell |
3,362
-3,124
| -48% | -$284K | 0.16% | 64 |
|
|
2023
Q2 | $525K | Sell |
6,486
-11,214
| -63% | -$907K | 0.24% | 50 |
|
|
2023
Q1 | $1.41M | Buy |
17,700
+11,758
| +198% | +$936K | 0.88% | 22 |
|
|
2022
Q4 | $402K | Buy |
+5,942
| New | +$402K | 0.25% | 55 |
|
|
2022
Q2 | – | Sell |
-5,440
| Closed | -$302K | – | 106 |
|
|
2022
Q1 | $302K | Buy |
5,440
+1,440
| +36% | +$79.9K | 0.14% | 76 |
|
|
2021
Q4 | $224K | Buy |
+4,000
| New | +$224K | 0.09% | 83 |
|